Vimarsana
Biggest News Aggregation in the World

Xin Tang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xin Tang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xin Tang Today - Breaking & Trending Today

Implantable Neural Probe Records Single-Neuron Activity Over Time - Vimarsana News

Implantable Neural Probe Records Single-Neuron Activity Over Time

Large-scale, long-term recordings of the activity of individual brain neurons are essential for improving our knowledge of neural circuits, developing new medical device-based treatments, and, eventually, developing brain-computer interfaces that need high-resolution electrophysiological data.

New brain implant records neuron activity for months - Vimarsana News

New brain implant records neuron activity for months

Recording the activity of large populations of single neurons in the brain over long periods of time is crucial to further our understanding of neural circuits, to enable novel medical device-based therapies and, in the future, for brain–computer interfaces requiring high-resolution electrophysiological information.

A long-lasting neural probe - Vimarsana News

A long-lasting neural probe

<p>An interdisciplinary team of researchers from the&nbsp;<a href="https://seas.harvard.edu/">Harvard John A. Paulson School of Engineering and Applied Sciences&nbsp;</a>(SEAS), in collaboration with The University of Texas at Austin, MIT and&nbsp;<a href="https://axoft.us/" target="_blank">Axoft, Inc</a>., developed a soft implantable device with dozens of sensors that can record single-neuron activity in the brain stably for months.</p>

Vestas extends partnership with wpd with onshore order in Taiwan - Vimarsana News

Vestas extends partnership with wpd with onshore order in Taiwan

News release from Vestas Asia Pacific Singapore, 18 November 2022 Vestas has secured a 21 MW order with wpd AG in Taiwan that includes five V117-4.2 MW turbines with 91.5m towers in two wind... | November 18, 2022

Thiazolidinedione Monotherapy for T2DM Tied to Lower Dementia Risk - Vimarsana News

Thiazolidinedione Monotherapy for T2DM Tied to Lower Dementia Risk

WEDNESDAY, Oct. 12, 2022 (HealthDay News) -- For patients with type 2 diabetes (T2D), thiazolidinedione (TZD) monotherapy is associated with reduced dementia risk compared with metformin (MET) monotherapy, while sulfonylurea (SU) monotherapy is associated with an increased risk, according to a study published online Oct. 12 in BMJ Open Diabetes Research & Care. Xin Tang,